Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
Moon Hee Lee, Petrus Järvinen, Harry Nísen, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 324
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
Yiwen Zheng, Shujin Li, Hongchao Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Zhu Zhao-yang, Yigang Jin, Jing Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients
Le Tong, Veronika Kremer, Shiyong Neo, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Analysis of mRNA Pentatricopeptide Repeat Domain 1 as a prospective oncogene in clear cell renal cell carcinoma that accelerates tumor cells proliferation and invasion via the Akt/GSK3β/β-catenin pathway
Zhongbao Zhou, Yulong Li, Yumeng Chai, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The diversity of natural killer cell functional and phenotypic states in cancer
Kumar Rishabh, Sandro Matosevic
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access
NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study
Amira Emad Elwy, Mahmoud Nassar, Shimaa Hassan Shaban, et al.
Pathology - Research and Practice (2025) Vol. 268, pp. 155863-155863
Closed Access
Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma
Ke Wang, M. Y. Yu, Zhouzhou Zhang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1270-1289
Open Access | Times Cited: 8
Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma
Chengbin Guo, Yuqin Tang, Qizhuo Li, et al.
Computers in Biology and Medicine (2023) Vol. 158, pp. 106872-106872
Closed Access | Times Cited: 7
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 7, pp. 1260-1276
Open Access | Times Cited: 6
Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach
Yali Niu, Xiaocan Jia, Nana Wang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Closed Access | Times Cited: 5
The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors
Sara Piccinelli, Rizwan Romee, Roman M. Shapiro
Seminars in Hematology (2023) Vol. 60, Iss. 1, pp. 42-51
Closed Access | Times Cited: 5
Heterogeneity in NK Cell Subpopulations May Be Involved in Kidney Cancer Metastasis
Zhengfang Liang, Fengwei Nong, Jingjie Zhao, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 9
TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma
Zhentao Zhang, Shuo Wang, Lu Ye, et al.
Journal of Cancer (2023) Vol. 14, Iss. 12, pp. 2181-2197
Open Access | Times Cited: 4
The tumor and plasma cytokine profiles of renal cell carcinoma patients
Moon Hee Lee, Essi Laajala, Anna Kreutzman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Natural Killer Cells, as the Rising Point in Tissues, Are Forgotten in the Kidney
Ke Ma, Zi-Run Zheng, Meng Yu
Biomolecules (2023) Vol. 13, Iss. 5, pp. 748-748
Open Access | Times Cited: 3
Computational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints
Otso Brummer, Petri Pölönen, Satu Mustjoki, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 4, pp. 683-695
Open Access | Times Cited: 3
Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer
Amir Hossein Aalami, Hossein Abdeahad, Farnoosh Aalami, et al.
Urologic Oncology Seminars and Original Investigations (2022) Vol. 41, Iss. 1, pp. 52.e1-52.e10
Closed Access | Times Cited: 5
Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma
Qihang Wu, Yuxiang Sun, Xiangcheng Qin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis
Yonggui Xiao, Chonghao Jiang, Hubo Li, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 10, pp. 2629-2645
Open Access | Times Cited: 2
Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma
Xuezhong Shi, Yali Niu, Yongli Yang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 3
Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
Zongyao Fan, Hewei Xu, Qingyu Ge, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Amplifying cancer chemoimmunotherapy through F4/80+CD11c+ DC-like macrophages induced by micellar docetaxel together with a TLR7/8 nanoagonist
Jinrong Peng, Qian Yang, Hong Jiang, et al.
Nano Today (2023) Vol. 54, pp. 102087-102087
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top